Work

Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?

Year: 2022

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2022.09.006

Authors: Vincenzo Di Noia, Fulvia Pimpinelli, Davide Renna, Flaminia Campo, Antonella Cosimati, Andrea Torchia, Benedetta Marcozzi, Alice Massacci, Matteo Pallocca, Raul Pellini, Aldo Morrone, Francesco Cognetti

Institutions: Instituto Nazionale Tumori Regina Elena, San Gallicano Hospital, Istituti di Ricovero e Cura a Carattere Scientifico, Sapienza University of Rome

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: National Cancer Institute

OpenAlex ID: W4303857446

FWCI: 0.565

Cites: 10

Cited by: 5

Related to: 10